News

MedWatch Update: Warning Issued on COVID-19 Drugs


The FDA has issued a warning against the use of hydroxychloroquine and chloroquine for COVID-19 outside a hospital or clinical trial setting due to the increased risk for heart rhythm issues. These medications have not been shown to be safe and effective for treating or preventing COVID-19. Earlier in the year, the FDA issued an …

Dr. Michael Nguyen Quoted in Risk & Insurance on the Importance of Biopsychosocial Care


The biopsychosocial model is an approach in medicine that aims to address the important links between biology, psychology and socio-environmental factors that affect patients throughout the care process. In a recent article for Risk & Insurance Magazine, myMatrixx Director of Clinical Pharmacy, Dr. Michael Nguyen, shared his thoughts about the positive impact this model can …

myMatrixx Releases New Report on the Impact of an Aging Workforce


With an aging population that is increasingly choosing to stay in the workforce past the standard retirement age, new issues are emerging in the field of workers’ compensation and workplace medical management. In light of these trends, myMatrixx has published a report on this topic, titled “Preparing for the Boom: Is your Medical Management Program …

New York Workers’ Comp Board Extends Formulary Deadline for Prescription Renewals to January 1, 2021


Due to the unprecedented health care challenges caused by the COVID-19 pandemic, the New York State Workers’ Compensation Board has extended the deadline for providers to obtain prior authorization for renewals of non-formulary medications. The previous deadline of June 5, 2020, has now been moved to January 1, 2021. This means that the formulary implementation …